Camlin Fine Sciences Promoter Creates Additional Share Pledge Worth ₹15.29 Crore

Camlin Fine Sciences Limited promoter Ashish S. Dandekar has disclosed the creation of additional share pledges worth ₹15.29 crore through two separate transactions in March 2026. The disclosures were made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Share Pledge Details

The promoter executed two pledge transactions within a span of five days:

Transaction Date:	Shares Pledged	Share Value	Percentage of Total Capital
March 20, 2026:	6.25 lakh	₹7.42 crore	0.33%
March 25, 2026:	7.00 lakh	₹7.88 crore	0.36%
Total:	13.25 lakh	₹15.29 crore	0.69%

Promoter Shareholding Position

Ashish S. Dandekar holds a significant stake in the company with the following shareholding structure:

Parameter:	Details
Total Promoter Holding:	1.98 crore shares
Percentage of Total Capital:	10.30%
Encumbered Shares (Post-Event):	74.07% of promoter holding
Previous Encumbered Percentage:	70.53%

Purpose and Security Arrangements

Both pledge transactions were created as additional margin pledges to cover shortfall in security cover. The March 20 pledge relates to financial assistance obtained by the target company, while the March 25 pledge pertains to financial assistance obtained for acquiring shares of the target company.

The shares have been pledged in favor of LRSD Securities Private Limited, which has been identified as a scheduled commercial bank, public financial institution, NBFC, or housing finance company in the disclosure documents.

Regulatory Compliance

The encumbered shares represent more than 50% of the promoter's shareholding, triggering mandatory disclosure requirements under SEBI SAST Regulations. However, the encumbered portion does not exceed 20% of the company's total share capital, keeping it below the threshold for additional regulatory scrutiny.

The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited, and the disclosure has been submitted to both exchanges along with the company secretary as per regulatory requirements.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-6.09%	-18.45%	-25.06%	-51.80%	-37.58%	-19.12%

Camlin Fine Sciences has received a court order initiating judicial liquidation proceedings for CFS Europe S.p.A., its wholly owned European subsidiary. The Ordinary Court of Ravenna, Italy issued the order on March 17, 2026, following an appeal filed by the subsidiary's Board of Statutory Auditors.

Court Order and Legal Framework

The judicial liquidation proceedings have been initiated under the Italian Code of Corporate Crisis and Insolvency. The Court has appointed a delegated Judge and Court-appointed Liquidators (Curatori) to manage the liquidation procedure, ensuring a structured and transparent resolution process.

Legal Proceedings Details:	Information
Court:	Ordinary Court of Ravenna, Italy
Order Date:	March 17, 2026
Legal Framework:	Italian Code of Corporate Crisis and Insolvency
Appeal Filed By:	Board of Statutory Auditors
Appeal Date:	January 15, 2026

Financial Impact on Parent Company

The subsidiary's contribution to Camlin Fine Sciences' overall business operations shows significant exposure. As of March 31, 2025, CFS Europe S.p.A. represented a notable portion of the parent company's financial metrics.

Financial Contribution (March 31, 2025):	Amount	Percentage
Turnover:	₹7,873.81 Lakhs	4.72%
Net Worth:	₹8,512.36 Lakhs	9.73%

Regulatory Compliance and Disclosure

Camlin Fine Sciences has made the disclosure under Regulation 30 and Schedule III of the SEBI Listing Regulations. The company indicated that repayment of liquidation proceeds, if any, will occur after completion of the judicial liquidation proceedings.

The liquidation process is currently underway, with the company stating that further updates will be provided as material developments occur. This represents a significant corporate restructuring action affecting the company's international operations and European market presence.